Navigation Links
InControl Medical LLC Announces Significant Second Quarter Sales Increase
Date:7/11/2013

Brookfield, Wisconsin (PRWEB) July 11, 2013

InControl Medical LLC announced Monday that second quarter sales increased more than 50 percent over the first quarter.

Leading the way in driving this sales increase is InControl’s female urinary incontinence product, InTone. The product has continued to achieve a better than 90% success rate in preventing bladder leakage, and word continues to spread about its effectiveness.

“A significant increase in re-orders from our physician network drove sales in the second quarter,” said Herschel Peddicord, President and CEO of InControl Medical. “We are pleased that more and more medical professionals continue to use and recommend InTone.”

InTone works to solve female urinary incontinence by employing a variety of patented muscle stimulation algorithms, active resistance and biofeedback to dramatically increase the strength of the pelvic floor muscles. Additionally, the device sends a calming signal to the detrusor muscle to decrease spasm and retains the muscle to create more functional voiding.

Patients work with their physician to customize InTone to fit their needs. Every patient then takes part in InTone sessions in the comfort and privacy of their own home, monitoring their progress along the way. Throughout the entire process, the patient continues to stay in touch with her doctor to tweak the device and treatment to fit her needs.

“InTone has received rave reviews from medical professionals and patients alike,” said Peddicord. “We are eager to continue to reach as many people as possible with the product to help women overcome urinary incontinence symptoms. This second-quarter sales growth is truly encouraging.”

For more information about InTone and whether or not it is right for you, visit the InControl Medical website at http://www.incontrolmedical.com.

About InControl Medical LLC

InControl Medical LLC is a women’s health company focusing on female urinary incontinence. Its product, InTone, is an innovatively designed product holding many patents, manufactured and designed in the United States. InTone provides the most effective, non-invasive treatment for stress, urge and mixed female urinary incontinence. The device requires no surgery and has no side effects. For more information about InControl Medical or InTone, visit http://www.incontrolmedical.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10918633.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Laura Rosenfield, M.D., Receives InTone Specialist Certification To Treat Female Urinary Incontinence From InControl Medical, LLC
2. Garland Andres, NP-C, Receives InTone Specialist Certification To Treat Female Urinary Incontinence From InControl Medical, LLC
3. Christopher Jayne, M.D., Receives InTone Specialist Certification To Treat Female Urinary Incontinence From InControl Medical, LLC
4. James J. Bendell, MD, Receives InTone Specialist Certification to Treat Female Urinary Incontinence from InControl Medical, LLC
5. Dr. Farhina Imtiaz Receives InTone Specialist Certification to Treat Female Urinary Incontinence from InControl Medical, LLC
6. Chary Tamirisa, MD, FACOG, Receives InTone Specialist Certification To Treat Female Urinary Incontinence From InControl Medical, LLC
7. Physician Groups Call for Fewer Medical Tests
8. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
9. CAM therapy combined with conventional medical care may improve treatment of lower back pain
10. Image share project gives patients and physicians anytime, anywhere access to medical images
11. Researchers determine vitamin D blood level for reducing major medical risks in older adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... 24, 2017 , ... The Smart Machine Age is here, and it’s disrupting ... percent of all jobs in the United States may be taken over by technology ... the aggressive know-it-all who steamrolls over colleagues is drawing to a close. Success will ...
(Date:2/24/2017)... Australia (PRWEB) , ... February 24, 2017 , ... The ... AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes ... stress disorder and his attempts to overcome them. , Schanssema, initially unsure of ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology: